Showing results (471-480 of 563) with videos related to

Sort By:
Pageof 57
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical RecurrenceJeremie Calais, Wolfgang P Fendler, Matthias Eiber, et al.
The Prostate|September 1, 2020
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meetingAndrea K Miyahira, Kenneth J Pienta, John W Babich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical ProstatectomyJohn Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)René-Jean Bensadoun, Karen Bénézery, Olivier Dassonville, et al.
Leukemia & Lymphoma|May 1, 2025
Adverse late outcomes in long-term survivors of young adult Hodgkin lymphoma (YAHL) compared to their unaffected co-twinsMarcie D Haydon, Amie E Hwang, Niquelle Brown Wadé, et al.
European Urology|December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy PlanningJeremie Calais, Johannes Czernin, Minsong Cao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2000
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative studyJ C Horiot, F Lipinski, S Schraub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2019
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate CancerWolfgang P Fendler, Manuel Weber, Amir Iravani, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2024
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trialChristian Borel, Xu-Shan Sun, Alexandre Coutte, et al.
Pageof 57